The electronic nose as a diagnostic tool in the discrimination of COPD and controls
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
N. Fens, MD1, M.P.C. van der Schee, BSc1, D. Cheung, MD,PhD2, E. Dijkers1, S.B. de Nijs1, P.J.E. Bindels, MD,PhD1, E.H.D. Bel, MD,PhD1 and P.J. Sterk, MD,PhD1. 1Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands and 2Vlietland Hospital, Schiedam, Netherlands. COPD can be Discriminated from Controls by Fingerprint Analysis of Volatile Organic Compounds in Exhaled Air using eNose Technology. Abstract ATS 2008.
- N. Fens, N.Fens@amc.nl, MD1, M.P.C. van der Schee, M.P.C.van_der_Schee@lumc.nl1, S.B. de Nijs, S.B.deNijs@amc.nl1, E. Dijkers, E.Dijkers@amc.nl1, Prof. Dr E.H. Bel, E.H.Bel@amc.nl, MD1 and Prof. Dr P.J. Sterk, P.J.Sterk@amc.nl, MD1. 1Respiratory Medicine, Academic Medical Center, Amsterdam, Netherlands. Exhaled breath molecular profiling in measuring inflammatory status in COPD http://www.ncbi.nlm.nih.gov/pubmed/19713445?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. COPD patients
- •2. A minimum of ten patients 40-75 years with moderate to severe COPD:
排除标准
- •Two or more of the following:
- •Severe cardiovascular disease, history or present